tiprankstipranks
Trending News
More News >
Global Health Limited (IN:MEDANTA)
:MEDANTA
India Market
Advertisement

Global Health Limited (MEDANTA) Stock Forecast & Price Target

Compare
2 Followers
See the Price Targets and Ratings of:

MEDANTA Financial Forecast

MEDANTA Earnings Forecast

The previous quarter’s earnings for MEDANTA were ₹5.90.
The previous quarter’s earnings for MEDANTA were ₹5.90.

MEDANTA Sales Forecast

Next quarter’s sales forecast for MEDANTA is ₹10.53B with a range of ₹10.53B to ₹10.53B. The previous quarter’s sales results were ₹10.99B. MEDANTA beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 47.55% of the time in the same period. In the last calendar year MEDANTA has Performed in-line its overall industry.
Next quarter’s sales forecast for MEDANTA is ₹10.53B with a range of ₹10.53B to ₹10.53B. The previous quarter’s sales results were ₹10.99B. MEDANTA beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 47.55% of the time in the same period. In the last calendar year MEDANTA has Performed in-line its overall industry.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TR | OpenAI - 4o Analyst forecast on IN:MEDANTA
TR | OpenAI - 4o
TR | OpenAI - 4o
₹1,445₹1,270
Hold
1.47%
Upside
Downgraded
11/11/25
AI Generated ArticleAI Generated Article
Jefferies Analyst forecast on IN:MEDANTA
Jefferies
Jefferies
₹1,380₹1,530
Buy
22.24%
Upside
Reiterated
08/12/25
Jefferies Sticks to Their Buy Rating for Global Health Limited (MEDANTA)
J.P. Morgan Analyst forecast on IN:MEDANTA
J.P. Morgan
J.P. Morgan
₹1,240₹1,480
Hold
18.24%
Upside
Reiterated
08/11/25
J.P. Morgan Keeps Their Hold Rating on Global Health Limited (MEDANTA)
HSBC
₹965₹1,200
Sell
-4.13%
Downside
Reiterated
08/11/25
HSBC Reaffirms Their Sell Rating on Global Health Limited (MEDANTA)
Kotak Mahindra Analyst forecast on IN:MEDANTA
Kotak Mahindra
Kotak Mahindra
₹1,275₹1,460
Buy
16.65%
Upside
Reiterated
08/11/25
Kotak Mahindra Remains a Buy on Global Health Limited (MEDANTA)Kotak analyst Alankar Garude raised the price target on Global Health Limited (MEDANTA:IN) to INR1,460.00 (from INR1,275.00) while maintaining a Add (2) rating.
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TR | OpenAI - 4o Analyst forecast on IN:MEDANTA
TR | OpenAI - 4o
TR | OpenAI - 4o
₹1,445₹1,270
Hold
1.47%
Upside
Downgraded
11/11/25
AI Generated ArticleAI Generated Article
Jefferies Analyst forecast on IN:MEDANTA
Jefferies
Jefferies
₹1,380₹1,530
Buy
22.24%
Upside
Reiterated
08/12/25
Jefferies Sticks to Their Buy Rating for Global Health Limited (MEDANTA)
J.P. Morgan Analyst forecast on IN:MEDANTA
J.P. Morgan
J.P. Morgan
₹1,240₹1,480
Hold
18.24%
Upside
Reiterated
08/11/25
J.P. Morgan Keeps Their Hold Rating on Global Health Limited (MEDANTA)
HSBC
₹965₹1,200
Sell
-4.13%
Downside
Reiterated
08/11/25
HSBC Reaffirms Their Sell Rating on Global Health Limited (MEDANTA)
Kotak Mahindra Analyst forecast on IN:MEDANTA
Kotak Mahindra
Kotak Mahindra
₹1,275₹1,460
Buy
16.65%
Upside
Reiterated
08/11/25
Kotak Mahindra Remains a Buy on Global Health Limited (MEDANTA)Kotak analyst Alankar Garude raised the price target on Global Health Limited (MEDANTA:IN) to INR1,460.00 (from INR1,275.00) while maintaining a Add (2) rating.
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Global Health Limited

1 Month
xxx
Success Rate
2/4 ratings generated profit
50%
Average Return
-1.15%
reiterated a xxx
rating 4 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 50.00% of your transactions generating a profit, with an average return of -1.15% per trade.
3 Months
xxx
Success Rate
1/4 ratings generated profit
25%
Average Return
+0.05%
reiterated a xxx
rating 4 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 25.00% of your transactions generating a profit, with an average return of +0.05% per trade.
1 Year
Success Rate
2/4 ratings generated profit
50%
Average Return
+4.40%
reiterated a sell rating 4 months ago
Copying Damayanti Kerai's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of +4.40% per trade.
2 Years
xxx
Success Rate
2/4 ratings generated profit
50%
Average Return
+4.40%
reiterated a xxx
rating 4 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 50.00% of your transactions generating a profit, with an average return of +4.40% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

MEDANTA Analyst Recommendation Trends

Rating
Jul 25
Aug 25
Sep 25
Oct 25
Nov 25
Strong Buy
0
0
0
0
0
Buy
10
11
10
4
2
Hold
1
2
1
1
1
Sell
2
3
2
1
0
Strong Sell
0
0
0
0
0
total
13
16
13
6
3
In the current month, MEDANTA has received 2 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. MEDANTA average Analyst price target in the past 3 months is .
Each month's total comprises the sum of three months' worth of ratings.

MEDANTA Stock Forecast FAQ

What is IN:MEDANTA’s average 12-month price target, according to analysts?
Currently, no data Available
What is IN:MEDANTA’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for IN:MEDANTA, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is Global Health Limited a Buy, Sell or Hold?
      Global Health Limited has a consensus rating of Moderate Buy, which is based on 0 buy ratings, 0 hold ratings and 0 sell ratings.
        What is Global Health Limited’s share price target?
        Currently, no data Available
        What do analysts say about Global Health Limited?
        Global Health Limited’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 0 Wall Streets Analysts.
          How can I buy shares of Global Health Limited?
          To buy shares of IN:MEDANTA, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis